Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, $0.01 par value per share
-
Shares outstanding
-
81.1M
-
Number of holders
-
177
-
Total 13F shares, excl. options
-
91M
-
Shares change
-
+3.74M
-
Total reported value, excl. options
-
$1.75B
-
Value change
-
+$57.7M
-
Put/Call ratio
-
1.92
-
Number of buys
-
107
-
Number of sells
-
-65
-
Price
-
$19.17
Significant Holders of Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN) as of Q4 2024
217 filings reported holding VRDN - Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share as of Q4 2024.
Viridian Therapeutics, Inc.\DE - Common Stock, $0.01 par value per share (VRDN) has 177 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 91M shares
.
Largest 10 shareholders include FMR LLC (11.9M shares), BlackRock, Inc. (5.76M shares), VANGUARD GROUP INC (4.6M shares), Deep Track Capital, LP (4.52M shares), VR Adviser, LLC (3.88M shares), STATE STREET CORP (3.52M shares), Fairmount Funds Management LLC (3.45M shares), Kynam Capital Management, LP (3.33M shares), TANG CAPITAL MANAGEMENT LLC (2.49M shares), and COMMODORE CAPITAL LP (2.4M shares).
This table shows the top 177 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.